5th International conference on Cancer Prevention and Research

ematology plays a pivotal role in understanding the blood-related aspects of cancer, including its diagnosis, progression, treatment response, and overall patient care. This session will focus on the complex interactions between blood disorders and various types of cancers, highlighting how advances in cancer prevention, oncology research, and cancer therapy research are transforming clinical practice. By integrating insights from cancer epidemiology, early detection, and public health interventions, haematology helps improve cancer screening, reduce risks of blood-related malignancies, and optimize therapeutic strategies. Participants will explore innovative diagnostic tools, preventive oncology approaches, and novel treatments that contribute to improved outcomes in cancer research and healthcare strategies worldwide. 

Hematologic Malignancies: Leukemia, Lymphoma, and Myeloma 

This sub-topic focuses on the pathophysiology, molecular mechanisms, and treatment advancements for common blood cancers including leukemia, lymphoma, and myeloma. It highlights how innovative therapies improve survival outcomes and shape global cancer initiatives. 

Hematopoietic Stem Cell Transplantation in Oncology 

Stem cell transplantation is a vital therapy for hematologic cancers. This sub-topic explores breakthroughs in allogeneic and autologous transplantation, its role in relapse prevention, and strategies to enhance cancer therapy research and patient recovery. 

Anemia and Coagulation Disorders in Cancer Patients 

Cancer and its treatments often lead to hematologic complications such as anemia and coagulation disorders. This sub-topic examines their pathogenesis, management strategies, and their impact on patient outcomes and preventive oncology practices. 

Hematologic Biomarkers for Early Cancer Detection and Prognosis 

Biomarkers derived from blood and bone marrow samples are crucial for cancer screening and disease monitoring. This sub-topic discusses emerging hematologic biomarkers that guide early detection, prognosis prediction, and precision-based cancer prevention strategies. 

Immunohematology and Blood-Based Therapeutic Innovations 

Immunohematology focuses on immune system interactions with blood components in cancer patients. This sub-topic explores how immune profiling and blood-based therapies contribute to cancer therapy research, improving personalized care and reducing cancer-related complications. 

Molecular Hematology in Cancer Diagnosis and Targeted Treatment 

This sub-topic highlights the use of molecular techniques to diagnose hematologic malignancies and guide targeted therapies. It emphasizes the role of genetic and molecular profiling in improving treatment decisions and cancer risk reduction strategies.